Growth Metrics

Novavax (NVAX) Long-Term Debt Repayments (2016 - 2023)

Novavax has reported Long-Term Debt Repayments over the past 7 years, most recently at $325.0 million for Q1 2023.

  • Quarterly results put Long-Term Debt Repayments at $325.0 million for Q1 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $325.0 million (changed N/A YoY), and the annual figure for FY2023 was $325.0 million, changed.
  • Long-Term Debt Repayments for Q1 2023 was $325.0 million at Novavax, up from $19000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for NVAX hit a ceiling of $325.0 million in Q1 2023 and a floor of $325.0 million in Q1 2023.